Buy Semaglutide in the Midwest — $99/Month | Trimi Health
The Midwest has the highest adult obesity rate in the nation at 35.9%. Trimi delivers compounded semaglutide to Midwest residents for $99/month — no clinic visits, no insurance required, shipped in 3–5 business days.
More on GLP-1 by Location
Why the Midwest Needs Affordable Semaglutide Access
The Midwest region — encompassing Ohio, Michigan, Indiana, Illinois, Wisconsin, Iowa, Missouri, Minnesota, Nebraska, Kansas, North Dakota, and South Dakota — faces the highest adult obesity rate in the United States at 35.9%. This statistic represents millions of Midwest residents who could benefit from effective weight management treatment but face barriers including cost, distance to specialty clinics, and limited insurance coverage for GLP-1 medications.
In-person weight loss clinics across the Midwest typically charge $250–$550 per month for compounded semaglutide programs. Brand-name Wegovy costs $1,000–$1,400 per month at Midwest pharmacies. For many Midwest families, these prices make effective obesity treatment inaccessible — even as the health consequences of untreated obesity continue to grow.
Midwest GLP-1 Snapshot
Region: 12 states, ~68 million people. Adult obesity rate: 35.9% (highest nationally). Typical clinic cost: $250–$550/mo. Brand Wegovy: $1,000–$1,400/mo. Trimi telehealth: $99/mo semaglutide, $125/mo tirzepatide. Serves all Midwest states via telehealth.
Trimi's telehealth model is designed to serve the Midwest's unique challenges. Whether you're in a major metro like Columbus or Detroit, a mid-size city like Cedar Rapids or Green Bay, or a rural community hours from the nearest weight loss clinic, Trimi delivers compounded semaglutide for $99/month. Learn more about how telehealth prescribing works. You can also read about Ozempic vs. Wegovy or explore our GLP-1 beginner guide.
Midwest Pricing: Trimi vs Local Providers & Pharmacies
Across the Midwest, weight loss clinics, med-spas, and pharmacies offer semaglutide at widely varying prices. Here is how Trimi compares to typical Midwest options.
| Option | Monthly Cost | In-Person Visit | Insurance Required |
|---|---|---|---|
| Midwest Weight Loss Clinic (avg) | $250–$550 | Yes | Sometimes |
| Midwest Pharmacy (brand Wegovy) | $1,000–$1,400 | Yes | Recommended |
| Trimi Telehealth (compounded) | $99/mo (sema) / $125/mo (tirz) | No | No |
Interested in understanding the difference between medications? Read our semaglutide vs. tirzepatide comparison. You can also learn about whether you qualify for GLP-1 treatment.
How It Works: 3 Steps to Get Semaglutide in the Midwest
Step 1: Online Health Intake
Complete a comprehensive health questionnaire covering your medical history, current medications, BMI, and weight loss goals — from anywhere in the Midwest.
Step 2: Provider Review & Prescription
A licensed provider evaluates your submission, confirms GLP-1 candidacy, and creates a dosing protocol. Your prescription is sent to a licensed compounding pharmacy.
Step 3: Delivered to Your Midwest Door
Temperature-controlled packaging arrives at your Midwest address within 3–5 business days. Monthly refills ship automatically to all 12 Midwest states.
New to GLP-1 medications? Check out our guide on compounded medication safety standards.
Available Medications for Midwest Residents
Compounded Semaglutide
$99/month
- Same active ingredient as Wegovy
- Weekly self-injection
- ~15% average weight loss at 68 weeks
- No insurance required
Compounded Tirzepatide
$125/month
- Dual GLP-1/GIP receptor agonist
- Weekly self-injection
- ~22% average weight loss at 72 weeks
- No insurance required
Unsure which medication fits your needs? Read our combining GLP-1 medication with diet and exercise for a detailed breakdown. You can also learn about what to expect your first month on semaglutide.
Semaglutide and Weight Management Across the Midwest
The Midwest offers diverse opportunities for combining semaglutide with an active lifestyle — from the Great Lakes shorelines to prairie trails, urban parks, and community fitness centers found in cities and towns across the region. Pairing semaglutide treatment with regular physical activity produces the best weight loss outcomes for Midwest residents.
Semaglutide works by mimicking the GLP-1 hormone to reduce appetite and slow gastric emptying. Clinical trials showed participants achieved ~15% average weight loss at 68 weeks. For the nearly 25 million Midwest adults living with obesity, Trimi makes this treatment accessible at $99/month with no insurance requirements and no clinic visits.
Learn more about managing GLP-1 side effects to maximize your results. You might also find our guide on semaglutide dosing schedule helpful as you begin your journey.
Getting Started with Trimi in the Midwest
Midwest residents with a BMI of 27 or higher (with at least one weight-related health condition) or a BMI of 30 or higher may be candidates for GLP-1 treatment through Trimi. The entire process — from online intake to first delivery — takes approximately 3–5 business days for Midwest addresses.
Whether you're in Ohio, Michigan, Indiana, Illinois, Wisconsin, Iowa, Missouri, Minnesota, Nebraska, Kansas, North Dakota, or South Dakota, Trimi ships medication directly to your door. All Midwest states support telehealth prescribing of GLP-1 medications, making Trimi accessible to residents across the entire region.
Ready to Start in the Midwest?
Get compounded semaglutide delivered to any Midwest address for $99/month. No office visit, no insurance, no waiting room.
Get Started for $99/MonthFrequently Asked Questions: Semaglutide in the Midwest
Can I get semaglutide anywhere in the Midwest without visiting a clinic?
Yes. Trimi offers compounded semaglutide entirely through telehealth across all Midwest states including Ohio, Michigan, Indiana, Illinois, Wisconsin, Iowa, Missouri, Minnesota, Nebraska, Kansas, North Dakota, and South Dakota. Complete an online intake, receive a provider evaluation, and get medication shipped directly to your door.
Why does the Midwest have the highest obesity rate in the U.S.?
The Midwest's 35.9% adult obesity rate reflects a combination of factors including dietary patterns, limited access to specialty healthcare in rural areas, economic challenges, and longer winters that reduce outdoor physical activity. Telehealth programs like Trimi help bridge the access gap for Midwest residents.
How fast is shipping to Midwest addresses?
Most Midwest residents receive their compounded semaglutide within 3–5 business days after prescription approval. Trimi ships to all Midwest states with temperature-controlled packaging to ensure medication quality regardless of weather conditions.
Is telehealth prescribing legal across all Midwest states?
Yes. All Midwest states — Ohio, Michigan, Indiana, Illinois, Wisconsin, Iowa, Missouri, Minnesota, Nebraska, Kansas, North Dakota, and South Dakota — permit licensed providers to conduct telehealth evaluations and prescribe GLP-1 medications. Trimi operates in compliance with each state's telehealth regulations.
Does Trimi offer tirzepatide as well as semaglutide in the Midwest?
Yes. Trimi offers both compounded semaglutide at $99/month and compounded tirzepatide at $125/month for residents across all Midwest states. During your online consultation, a licensed provider will help determine which medication best fits your health goals.
How does Trimi pricing compare to Midwest weight loss clinics?
Midwest weight loss clinics typically charge $250–$550 per month for compounded semaglutide, while brand-name Wegovy runs $1,000–$1,400/month. Trimi delivers the same compounded semaglutide for $99/month with no insurance required and no clinic visits — saving Midwest families hundreds per month.
Can rural Midwest residents access Trimi?
Absolutely. Trimi's telehealth model is especially valuable for rural Midwest communities where weight loss clinics may be hours away. As long as you have a mailing address for delivery and internet access for the online intake, Trimi can serve you anywhere in the Midwest.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescription medications requiring evaluation by a licensed healthcare provider. Individual results vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- CDC Adult Obesity Prevalence Maps — Midwest Region Data 2023.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).